COMPARISON OF DIFFERENCE-IN-DIFFERENCE AND PROPENSITY SCORE METHODS IN REGRESSIONS WITH BINARY OUTCOMES

Author(s)

Cao Z1, Margolis J2, Mark T31Thomson Reuters, Cambridge, MA, USA, 2Thomson Reuters, Bala Cynwyd, PA, USA, 3Thomson Reuters, Washington, DC, USA

Objective: Difference-in-difference (DID) and propensity score matching (PSM) methods are two ways of evaluating the effect of changes in policies influencing drug prescribing or medications.  The objective of this study is to compare and contrast the strengths and weakness and different types of information provided by the DID and PSM methods in the context of determining the impact of an insurance plan restriction on binary health care utilization outcomes. Data: Adult patients diagnosed with diagnosis A were selected from MarketScan® Commercial Database (2005-2007), a large claims data form persons with employ-based insurance. Methodology:  The DID analysis was implemented by a GEE regression with logit link, binomial variance function, and exchangeable correlation structure on panel data with pre- and post-restriction period. The dependent variables included inpatient hospitalization, ER visit, use of alternative drug B, and use of alternative drug C. The key independent variables included an indicator for plan restriction, an indicator for pre- or post- restriction period, and an interaction term between them. Demographic and clinical characteristics were included as covariates. The odds ratios (OR) of the interaction terms were considered as the DID estimates. In the PSM method, patients in restricted and unrestricted plans were propensity score matched based on pre-implementation characteristics, followed by logistic regressions. Results: Without controlling for any covariate, the restriction effects were non-significant on all outcomes using DID analysis. The restriction effects were significant for ER visit and hospitalization using PSM. When all characteristics were controlled, the restriction effects were non-significant in both methods, except the outcome of drug B use. Conclusion: DID and PSM- based methods may produce different estimates. Neither method can fully control all potential confounders. Compared with the PSM method, DID method uses same individual as the control, but is restricted to studies when pre- and post-event data are available.

Conference/Value in Health Info

2010-05, ISPOR 2010, Atlanta, GA, USA

Value in Health, Vol. 13, No. 3 (May 2010)

Code

PMC46

Topic

Clinical Outcomes

Topic Subcategory

Relating Intermediate to Long-term Outcomes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×